A somatic analysis of ctDNA and tumor tissue revealed a mutational landscape like mCRPC, although without AR gene alterations: TP53 and DDR gene mutations were identified in 47% and 21% of the cases, respectively. The gene discussed is AR; the disease is neoplasm.